The Brexit Effect: What Would It Mean For Europe's Future Patent System?
UK referendum on whether to remain in EU will take place around the time that the Unified Patent Court is expected to launch.
You may also be interested in...
UK vote to leave the EU opens the prospect of years of negotiations over the union's future relationship with one of its most valued member states.
Many of those in the life sciences sector who would be affected by a possible UK departure from the EU, including industry, scientists, the academic community and lawyers, have been happy to make their views known as to the likely effects. The voice of the drug regulators in this debate, though, has been understandably muted.
New European legislation and rules on trademarks and trade secrets, the transatlantic transfer of data, and anticounterfeiting measures advanced during February, while streamlining generics approvals were featured during the EU-US TTIP negotiations; the UK referendum on whether to exit the EU set for mid-June.